Benitec Biopharma Inc.·4

Dec 9, 7:21 PM ET

Francis Peter 4

4 · Benitec Biopharma Inc. · Filed Dec 9, 2022

Insider Transaction Report

Form 4
Period: 2022-12-07
Transactions
  • Award

    Options (right to buy)

    2022-12-07+12,00012,000 total
    Exercise: $0.17Exp: 2032-12-07Common Stock (12,000 underlying)
Footnotes (1)
  • [F1]The stock options will vest in three substantially equal installments on the day prior to each of the Issuer's next three annual stockholder meetings occurring immediately following the date of grant.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES